^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    bacillus Calmette-Guerin (BCG)

    Associations

    News

    Trials
    Company:
    Lacocca Family Foundation
    Drug class:
    TNF receptor modulator
    Related drugs:
    Associations

    News

    Trials
    6ms
    Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes (clinicaltrials.gov)
    P2, N=150, Active, not recruiting, Massachusetts General Hospital | Trial completion date: Jul 2027 --> Jul 2031 | Trial primary completion date: Jul 2025 --> Jul 2029
    Trial completion date • Trial primary completion date
    |
    bacillus Calmette-Guerin (BCG)